Market Tracker

01/18 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.29
Delayed Data
As of 3:56pm ET
 +0.04 / +0.64%
Today’s Change
5.60
Today|||52-Week Range
10.51
+2.78%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close6.25
Today’s open6.28
Day’s range6.13 - 6.30
Volume10,400
Average volume (3 months)33,283
Market cap$83.0M
Dividend yield--
Data as of 3:56pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book3.15

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.06+3.61%
TCONTRACON Pharmaceutica...+0.05+0.95%
FLKSFlex Pharma Inc-0.10-2.14%
SNSSSunesis Pharmaceutic...+0.11+2.86%
Data as of 4:00pm ET, 01/18/2017

Financials

Last reporting dateNovember 23, 2016
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts